Systematic characterization of extracellular vesicle sorting domains and quantification at the single molecule - single vesicle level by fluorescence correlation spectroscopy and single particle imaging.

CD63 EV double labelling EV engineering EV protein sorting domains Extracellular vesicles exosomes fluorescence correlation spectroscopy single vesicle imaging

Journal

Journal of extracellular vesicles
ISSN: 2001-3078
Titre abrégé: J Extracell Vesicles
Pays: United States
ID NLM: 101610479

Informations de publication

Date de publication:
2019
Historique:
received: 02 04 2019
revised: 20 08 2019
accepted: 21 08 2019
entrez: 4 10 2019
pubmed: 4 10 2019
medline: 4 10 2019
Statut: epublish

Résumé

Extracellular vesicles (EV) convey biological information by transmitting macromolecules between cells and tissues and are of great promise as pharmaceutical nanocarriers, and as therapeutic per se. Strategies for customizing the EV surface and cargo are being developed to enable their tracking, visualization, loading with pharmaceutical agents and decoration of the surface with tissue targeting ligands. While much progress has been made in the engineering of EVs, an exhaustive comparative analysis of the most commonly exploited EV-associated proteins, as well as a quantification at the molecular level are lacking. Here, we selected 12 EV-related proteins based on MS-proteomics data for comparative quantification of their EV engineering potential. All proteins were expressed with fluorescent protein (FP) tags in EV-producing cells; both parent cells as well as the recovered vesicles were characterized biochemically and biophysically. Using Fluorescence Correlation Spectroscopy (FCS) we quantified the number of FP-tagged molecules per vesicle. We observed different loading efficiencies and specificities for the different proteins into EVs. For the candidates showing the highest loading efficiency in terms of engineering, the molecular levels in the vesicles did not exceed ca 40-60 fluorescent proteins per vesicle upon transient overexpression in the cells. Some of the GFP-tagged EV reporters showed quenched fluorescence and were either non-vesicular, despite co-purification with EVs, or comprised a significant fraction of truncated GFP. The co-expression of each target protein with CD63 was further quantified by widefield and confocal imaging of single vesicles after double transfection of parent cells. In summary, we provide a quantitative comparison for the most commonly used sorting proteins for bioengineering of EVs and introduce a set of biophysical techniques for straightforward quantitative and qualitative characterization of fluorescent EVs to link single vesicle analysis with single molecule quantification.

Identifiants

pubmed: 31579435
doi: 10.1080/20013078.2019.1663043
pii: 1663043
pmc: PMC6758720
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1663043

Informations de copyright

© 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of The International Society for Extracellular Vesicles.

Références

J Biotechnol. 2013 May 20;165(2):77-84
pubmed: 23562828
EMBO J. 2013 Apr 17;32(8):1115-27
pubmed: 23511973
Cytometry A. 2016 Feb;89(2):196-206
pubmed: 26484737
Nanomedicine. 2012 Jul;8(5):712-20
pubmed: 22024193
Adv Drug Deliv Rev. 2013 Mar;65(3):383-90
pubmed: 22921594
J Thorac Oncol. 2013 Sep;8(9):1156-62
pubmed: 23945385
Blood. 2005 Jul 1;106(1):216-23
pubmed: 15790784
Cell. 2001 Jul 27;106(2):145-55
pubmed: 11511343
J Cell Biochem. 2010 Oct 1;111(2):488-96
pubmed: 20533300
RNA Biol. 2017 Jan 2;14(1):58-72
pubmed: 27791479
Biochem Biophys Res Commun. 1996 May 6;222(1):13-8
pubmed: 8630057
J Biol Chem. 2015 Mar 27;290(13):8166-72
pubmed: 25657008
J Biol Chem. 2011 Apr 22;286(16):14383-95
pubmed: 21300796
J Extracell Vesicles. 2015 Apr 20;4:26316
pubmed: 25899407
Blood. 2004 Nov 15;104(10):3257-66
pubmed: 15284116
Stem Cell Res. 2010 May;4(3):214-22
pubmed: 20138817
Cancer Res. 2008 Feb 15;68(4):1228-35
pubmed: 18281500
Science. 2008 Feb 29;319(5867):1244-7
pubmed: 18309083
Nat Commun. 2018 Apr 3;9(1):1305
pubmed: 29610454
Nat Commun. 2018 Jun 15;9(1):2359
pubmed: 29907766
Anal Chem. 2018 Oct 2;90(19):11273-11279
pubmed: 30178994
J Extracell Vesicles. 2015 Mar 31;4:25530
pubmed: 25833224
Nat Cell Biol. 2012 Jun 03;14(7):677-85
pubmed: 22660413
Nat Biotechnol. 2011 Apr;29(4):341-5
pubmed: 21423189
Br J Cancer. 2015 Jul 14;113(2):275-81
pubmed: 26057451
Vaccine. 2011 Nov 21;29(50):9361-7
pubmed: 22001882
J Extracell Vesicles. 2015 Dec 07;4:28533
pubmed: 26649679
Oral Dis. 2010 Jan;16(1):34-8
pubmed: 19627513
J Extracell Vesicles. 2014 Dec 22;3:26913
pubmed: 25536934
Blood. 2005 Sep 1;106(5):1604-11
pubmed: 15741221
Curr Protoc Cell Biol. 2006 Apr;Chapter 3:Unit 3.22
pubmed: 18228490
Sci Rep. 2016 Mar 02;6:22519
pubmed: 26931825
Nat Commun. 2015 May 13;6:7029
pubmed: 25967391
Sci Rep. 2017 May 12;7(1):1878
pubmed: 28500324
Nephrol Dial Transplant. 2011 May;26(5):1474-83
pubmed: 21324974
J Proteome Res. 2010 Feb 5;9(2):761-76
pubmed: 19921851
Am J Cancer Res. 2011;1(1):98-110
pubmed: 21969178
Mol Biol Cell. 2013 Jun;24(11):1619-37, S1-3
pubmed: 23576546
Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4518-23
pubmed: 10200294
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17380-5
pubmed: 24101524
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14888-93
pubmed: 25267620
Mol Cell Biol. 2006 Oct;26(20):7707-18
pubmed: 16908530
Mol Ther. 2011 Oct;19(10):1769-79
pubmed: 21915101
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):E968-77
pubmed: 26858453
Blood Cells Mol Dis. 2005 Sep-Oct;35(2):158-68
pubmed: 16087368
Nat Protoc. 2012 Dec;7(12):2112-26
pubmed: 23154783
J Cell Biol. 2016 Apr 25;213(2):173-84
pubmed: 27114500
J Biol Chem. 1998 Aug 7;273(32):20121-7
pubmed: 9685355
Biomaterials. 2014 Feb;35(7):2383-90
pubmed: 24345736
J Cell Sci. 2011 Dec 1;124(Pt 23):3933-40
pubmed: 22194304
Sci Rep. 2017 Sep 14;7(1):11561
pubmed: 28912498
Nat Med. 2012 Jun;18(6):883-91
pubmed: 22635005
Biochim Biophys Acta Biomembr. 2018 Jun;1860(6):1350-1361
pubmed: 29551275
Nature. 2015 Jul 9;523(7559):177-82
pubmed: 26106858
Cancer Res. 2011 Aug 1;71(15):5235-44
pubmed: 21670078
PLoS One. 2009;4(3):e4942
pubmed: 19319200
Traffic. 2010 May;11(5):675-87
pubmed: 20136776
Cancer Res. 2011 Jun 1;71(11):3792-801
pubmed: 21478294
Cell Mol Immunol. 2017 May;14(5):465-475
pubmed: 27238466
J Extracell Vesicles. 2013 Jun 18;2:null
pubmed: 24009892
Biotechnol Bioeng. 2016 Jun;113(6):1315-24
pubmed: 26574179
Mol Biol Cell. 1996 Feb;7(2):193-207
pubmed: 8688552
Front Immunol. 2018 Apr 30;9:738
pubmed: 29760691
Sci Transl Med. 2018 Jun 6;10(444):
pubmed: 29875202
J Extracell Vesicles. 2019 Mar 21;8(1):1587567
pubmed: 30949308
PLoS One. 2013 Apr 16;8(4):e61916
pubmed: 23613971
Nanomedicine. 2015 May;11(4):879-83
pubmed: 25659648
J Extracell Vesicles. 2019 Feb 20;8(1):1582237
pubmed: 30815239
ACS Nano. 2018 Jan 23;12(1):494-503
pubmed: 29286635
Mol Ther. 2013 Jan;21(1):185-91
pubmed: 23032975
Mol Ther. 2016 Oct;24(10):1836-1847
pubmed: 27506293
Clin Chem. 2018 Apr;64(4):680-689
pubmed: 29453194

Auteurs

Giulia Corso (G)

Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.

Wolf Heusermann (W)

Novartis Institutes for Biomedical Research, Basel, Switzerland.
Imaging Core Facility, Biozentrum, University of Basel, Basel, Switzerland.

Dominic Trojer (D)

Novartis Institutes for Biomedical Research, Basel, Switzerland.

André Görgens (A)

Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Institute for Transfusion Medicine, University Hospital Essen, Essen, Germany.

Emmanuelle Steib (E)

Novartis Institutes for Biomedical Research, Basel, Switzerland.
Department of Cell Biology, Sciences III, University of Geneva, Geneva Switzerland.

Johannes Voshol (J)

Novartis Institutes for Biomedical Research, Basel, Switzerland.

Alexandra Graff (A)

Facility for advanced imaging and microscopy, Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.

Christel Genoud (C)

Facility for advanced imaging and microscopy, Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.

Yi Lee (Y)

Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Department of Cancer and Stratified Oncology 5, Astar Genome Institute of Singapore, Singapore.

Justin Hean (J)

Novartis Institutes for Biomedical Research, Basel, Switzerland.

Joel Z Nordin (JZ)

Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.

Oscar P B Wiklander (OPB)

Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.

Samir El Andaloussi (S)

Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.

Nicole Meisner-Kober (N)

Novartis Institutes for Biomedical Research, Basel, Switzerland.
Department of Biosciences, University of Salzburg, Salzburg, Austria.

Classifications MeSH